What to make of the results remains uncertain, but experts agree that greater vigilance in low-risk patients is warranted.

With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic valve implantation in a study presented today at ...

One medtech company is combining the power of artificial intelligence with transcatheter aortic valve implantation (TAVI) procedures. Caranx Medical said it filed for FDA submission for TAVIPILOT Soft ...

With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients ...

In a major step forward toward advance cardiac care, Medanta-The Medicity, Noida, has successfully carried out its first ...

Eight-year data from the NOTION trial again show no differences in clinical outcomes and bioprosthetic valve failure between TAVI and surgery among patients at low surgical risk, suggesting good ...

Transcatheter aortic valve implantation (TAVI) was superior to surgical aortic valve replacement for reducing death, stroke or rehospitalization in women with severe aortic stenosis, according to late ...

Abbott Laboratories, Inc. ABT recently announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) balloon-expandable system for treating symptomatic ...